1 / 5
The chemiluminescence immunoassay system uses magnetic particle separation technology, using magnetic particles as antibody carriers for even distribution in liquid phase reaction systems. This ensures faster reaction speeds and higher efficiency. Using the enzymatic chemiluminescence method, the light signal is more stable, providing higher sensitivity and faster luminescence.
| Parameter | BKI1100 | BKI2200 |
|---|---|---|
| Throughput | 80T/H | 120T/H |
| Principle | Magnetic particle enzymatic chemiluminescence | |
| Sample Positions | 60 (Supports emergency positioning) | |
| Reagent Positions | 30 pcs (2-8ºC refrigeration) | |
| Incubation Positions | 50 | 80 |
| Time to 1st Result | 18 Minutes | |
| Calibration Stability | 28 Days | |
| External Size (W*D*H) | 1120*735*513mm | 1305*770*1150mm |
| Thyroid | TSH, TT4, TT3, FT4, FT3, TgAb, TPOAb, TG, Anti-TSHR | Anemia | FERRITIN, VB12, FA |
| Fertility | β-HCG, E2, P, T, PRL, FSH, LH, DHEA-S | Tumor marker | CA125, CA15-3, CA199, AFP, CEA, t-PSA, f-PSA |
| Cardiac marker | cTnI, CK-MB, MYO, NT-proBNP | Inflammation | PCT, IL-6 |
| Bone Metabolism | BGP, 25-OH-Vit-D, iPTH | Diabetes | C-P, INS |